NewsRx

Search our medical news database

Drug Development

Asterand plc, Bristol-Myers Squibb Sign Further Agreements for Access to Asterand Products and Services

Published in Lab Business Week, June 3rd, 2007

Asterand plc (LSE: ATD), announced that it has entered into an extended collaboration with Bristol-Myers Squibb Company (NYSE: BMY) ("BMS") for access to Asterand's products and services for up to three years. The agreement will focus on access to Asterand's PhaseZERO(R) drug discovery services and Asterand's XpressBANK(TM) of human tissue and clinical samples for the continued validation of early drug targets and support for compound optimization. Financial terms were not disclosed.

"This decision by Bristol-Myers Squibb is an important validation of Asterand's products and services," says Asterand CEO Martyn Coombs. "Our goal is to assist Bristol-Myers Squibb and...

Want to see the full article?

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Buy Now


Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Lab Business Week


NewsRx is Social

Follow us on your favorite social network by clicking on a button below:

Follow NewsRx on Twitter

NewsRx on Facebook

Awards

eHealthcare Leadership 2011 Winner
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

  • Google 2010 PageRank: #2 Among Top Health News and Media Publications
  • Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
  • Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
  • Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx on Facebook